Amarnath Natarajan

Nebraska Medical Center — United States

Medicine · Health Sciences

32h-index3.5kcitations213works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(46), Acute Lymphoblastic Leukemia research(38), Ubiquitin and proteasome pathways(17), Lymphoma Diagnosis and Treatment(15), Cancer, Hypoxia, and Metabolism(15)

Publications213 total

Circulating Lipids Predict Mortality and Drive Immune Gene Regulation in Acute-on-Chronic Liver Failure
2025Open Access
Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics
Proteomes·2025Open Access
A New Class of Precision Therapeutics that Inhibit Prostate Cancer Mediated Bone Destruction
2025· 1 citedOpen Access
A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the Network
Molecules·2025Open Access
Abstract 7023: A phenotypic screening method identifies a potent anti-cancer PROTAC targeting MAP3K1
Cancer Research·2025
The role of Tyr34 in proton coupled electron transfer and product inhibition of manganese superoxide dismutase
Nature Communications·2025· 5 citedOpen Access
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders
RSC Advances·2025· 1 citedOpen Access
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Communications Biology·2024· 4 citedOpen Access
Small molecule targeting of FBXO21 mediated p85α ubiquitylation in acute myeloid leukemia
2024
Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3
Biomedicines·2024· 3 citedOpen Access
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders
2024· 2 citedOpen Access
Protein Structure Inspired Discovery of a Novel Inducer of Anoikis in Human Melanoma
Cancers·2024· 1 citedOpen Access
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Hemato·2024· 2 citedOpen Access
Domino Reactions Enable Zn-Mediated Direct Synthesis of Spiro-Fused 2-Oxindole-α-Methylene-γ-Butyrolactones/Lactams from Isatin Derivatives and 2-(Bromomethyl)acrylates
Molecules·2024· 1 citedOpen Access
Author response: DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
2024Open Access
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
eLife·2024· 6 citedOpen Access
GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior
Scientific Reports·2024· 11 citedOpen Access
The role of Tyr34 in proton-coupled electron transfer of human manganese superoxide dismutase
2024Open Access
The role of Tyr34 in proton-coupled electron transfer of human manganese superoxide dismutase
2024· 2 citedOpen Access
Figure S2 from Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
2024Open Access
page 1 of 11Next →

Frequent Co-authors

Sandeep Rana(17), Jacob I. Contreras(7), José A. Halperin(7), Smitha Kizhake(7), Yogesh A. Sonawane(6), Margaret Taylor(5), Yuhong Guo(5), Michael A. Hollingsworth(5), Srikumar M. Raja(4), Hamid Band(4), Smit Kour(4), Muhammad Zahid(4), Yun-Hua Fan(4), Hüseyin Aktaş(4), Michael Chorev(4), Rajkumar N. Rajule(4), Vashti C. Bryant(4), G.L. Lokesh(4), G.D. Kishore Kumar(4), Bhopal Mohapatra(3)